The use of vaccine against COVID-19 has been authorized by the Chinese Army in its ranks. The vaccine has been developed by a military research institute and a pharmaceutical company.
All over the world, laboratories are competing with each other to find a vaccine for the novel coronavirus. It is important to mention here that as per the info from the World Health Organisation (WHO) around half of the 17 vaccines that are being used in the clinical trials have been developed by the Chinese laboratories or institutes.
There is a Chinese company among these, CanSinoBIO that has joined hands with the Military Academy of Medical Sciences to introduce one of the most advanced coronavirus vaccines currently available.
The company in a statement on the Hong Kong Stock Exchange, where it is listed said, “Data from clinical trials have shown a good safety profile and high levels of humoral and cellular immune response.”
Right now it is not clear that if the approval would also include a vaccination campaign within the Chinese army that has around 2 million members. There was a request for comments from AFP, to which the defence ministry gave no response. The company also emphasized in its press release that there is no guarantee whether the vaccine can be marketed to the general public or not.